SEC Company Response from Tonix Pharmaceuticals Holding Corp. (TNXP) (CIK 0001430306) (TNXP) — Jul 24, 2013
Tonix Pharmaceuticals Holding Corp. (TNXP) (CIK 0001430306)
Date: July 24, 2013 · CIK: 0001430306 · Accession: 0001144204-13-040920
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-188547
Letter
Tonix Pharmaceuticals Holding Corp.
509 Madison Avenue, Suite 306
New York, New York 10022
July 24, 2013
VIA EDGAR
United States Securities
and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Attention: Adam Turk, Esq.
Re: Tonix Pharmaceuticals Holding Corp.
Registration Statement on Form S-1
File No. 333-188547
Ladies and Gentlemen:
Tonix Pharmaceuticals Holding Corp. hereby respectfully requests the withdrawal of its request for acceleration dated July 22, 2013, of the effective date of the registration statement referred to above that was requested to become effective at 4:00 p.m., Washington D.C. time, on Wednesday, July 24, 2012, or as soon thereafter as practicable.
TONIX PHARMACEUTICALS HOLDING CORP.
By: /s/ SETH LEDERMAN
Name: Seth Lederman
Title: Chief Executive Officer
Show Raw Text
CORRESP
1
filename1.htm
Tonix Pharmaceuticals Holding Corp.
509 Madison Avenue, Suite 306
New York, New York 10022
July 24, 2013
VIA EDGAR
United States Securities
and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Attention: Adam Turk, Esq.
Re: Tonix Pharmaceuticals Holding Corp.
Registration Statement on Form
S-1
File No. 333-188547
Ladies and Gentlemen:
Tonix Pharmaceuticals
Holding Corp. hereby respectfully requests the withdrawal of its request for acceleration dated July 22, 2013, of the effective
date of the registration statement referred to above that was requested to become effective at 4:00 p.m., Washington D.C.
time, on Wednesday, July 24, 2012, or as soon thereafter as practicable.
TONIX PHARMACEUTICALS HOLDING CORP.
By:
/s/ SETH LEDERMAN
Name: Seth Lederman
Title: Chief Executive Officer